Patents by Inventor Drew Smith
Drew Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20260050851Abstract: Disclosed herein are techniques for computationally efficient scoring and prioritization of resources. A method can include receiving a data request for a resource assignment in an operational environment, retrieving a queue of candidate resources associated with the operational environment, generating a dynamic score for at least one candidate resource in the queue of candidate resources based at least in part on the received data request, updating a prioritized resource list based on the dynamic score for the at least one candidate resource, the prioritized resource list including a group of resources having respective dynamic scores, assigning a resource from the prioritized resource list that satisfies one or more assignment criteria based on the received data request, and returning instructions that cause the assigned resource to be executed.Type: ApplicationFiled: October 27, 2025Publication date: February 19, 2026Inventors: Daniƫl Walet, Daniel Thomas Wintz, Noah James Garnier, Daniel Bolis, Kaitlyn Garifi, Drew Smith
-
Publication number: 20080278960Abstract: The present invention relates generally to illuminated ornamental and/or decorative sculptures and/or structures. More particularly, the present invention relates to an illuminated structure having a plurality of individual optical elements disposed thereon.Type: ApplicationFiled: July 17, 2008Publication date: November 13, 2008Inventors: Drew Smith, Susan Haug
-
Publication number: 20070274071Abstract: The present invention relates generally to illuminated ornamental and/or decorative sculptures and/or structures. More particularly, the present invention relates to an illuminated structure having a plurality of individual optical elements disposed thereon.Type: ApplicationFiled: May 24, 2006Publication date: November 29, 2007Inventors: Drew Smith, Susan Haug
-
Publication number: 20070134715Abstract: A method is described for generating blended nucleic acid ligands containing non-nucleic acid functional units. Specifically, a SELEX identified RNA ligand to the integrin gpIIbIIIa is conjugated to the peptide Gly-Arg-Gly-Asp-Thr-Pro (SEQ ID NO:1). This blended RNA ligand inhibits the biological activity of gpIIbIIIa with high specificity. Also described is a single-stranded DNA ligand to elastase coupled to N-methoxysuccinyl-Ala-Ala-Pro-Val-chloromethyl ketone (SEQ ID NO:2). This elastase blended nucleic acid ligand inhibits the biological activity of elastase.Type: ApplicationFiled: January 29, 2007Publication date: June 14, 2007Applicant: GILEAD SCIENCES, INC.Inventors: Greg Biesecker, Sumedha Jayasena, Larry Gold, Drew Smith, Gary Kirschenheuter
-
Patent number: 7176295Abstract: A method is described for generating blended nucleic acid ligands containing non-nucleic acid functional units. Specifically, a SELEX identified RNA ligand to the integrin gpIIbIIIa is conjugated to the peptide Gly-Arg-Gly-Asp-Thr-Pro (SEQ ID NO:1). This blended RNA ligand inhibits the biological activity of gpIIbIIIa with high specificity. Also described is a single-stranded DNA ligand to elastase coupled to N-methoxysuccinyl-Ala-Ala-Pro-Val-chloromethyl ketone (SEQ ID NO:2). This elastase blended nucleic acid ligand inhibits the biological activity of elastase.Type: GrantFiled: October 2, 2002Date of Patent: February 13, 2007Assignee: Gilead Sciences, Inc.Inventors: Gregory Biesecker, Sumeda Jayasena, Larry Gold, Drew Smith, Gary P. Kirschenheuter
-
Publication number: 20060088877Abstract: This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.Type: ApplicationFiled: December 6, 2005Publication date: April 27, 2006Applicant: GILEAD SCIENCES, INC.Inventors: Larry Gold, Bruce Eaton, Drew Smith, Matthew Wecker, Kirk Jensen
-
Publication number: 20030186231Abstract: This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.Type: ApplicationFiled: October 9, 2001Publication date: October 2, 2003Inventors: Larry Gold, Bruce Eaton, Drew Smith, Matthew Wecker, Kirk Jensen
-
Publication number: 20030077646Abstract: A method is described for generating blended nucleic acid ligands containing non-nucleic acid functional units. Specifically, a SELEX identified RNA ligand to the integrin gpIIbIIIa is conjugated to the peptide Gly-Arg-Gly-Asp-Thr-Pro (SEQ ID NO: 1). This blended RNA ligand inhibits the biological activity of gpIIbIIIa with high specificity. Also described is a single-stranded DNA ligand to elastase coupled to N-methoxysuccinyl-Ala-Ala-Pro-Val-chloromethyl ketone (SEQ ID NO: 2). This elastase blended nucleic acid ligand inhibits the biological activity of elastase.Type: ApplicationFiled: October 2, 2002Publication date: April 24, 2003Applicant: GILEAD SCIENCES, INC.Inventors: Greg Biesecker, Sumedha D. Jayasena, Larry Gold, Drew Smith, Gary P. Kirschenheuter
-
Patent number: 6465189Abstract: A method is described for generating blended nucleic acid ligands containing non-nucleic acid functional units. Specifically, a SELEX identified RNA ligand to the integrin gpIIbIIIa is conjugated to the peptide Gly-Arg-Gly-Asp-Thr-Pro (SEQ ID NO:1). This blended RNA ligand inhibits the biological activity of gpIIbIIIa with high specificity. Also described is a single-stranded DNA ligand to elastase coupled to N-methoxysuccinyl-Ala-Ala-Pro-Val-chloromethyl ketone (SEQ ID NO:2). This elastase blended nucleic acid ligand inhibits the biological activity of elastase.Type: GrantFiled: June 29, 2000Date of Patent: October 15, 2002Assignee: Gilead Sciences, Inc.Inventors: Greg Biesecker, Sumedha Jayasena, Larry Gold, Drew Smith, Gary Kirschenheuter
-
Patent number: 6300074Abstract: This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.Type: GrantFiled: October 4, 1999Date of Patent: October 9, 2001Assignee: Gilead Sciences, Inc.Inventors: Larry Gold, Bruce Eaton, Drew Smith, Matthew Wecker, Kirk Jensen
-
Patent number: 6083696Abstract: A method is described for generating blended nucleic acid ligands containing non-nucleic acid functional units. Specifically, a SELEX identified RNA ligand to the integrin gpIIbIIIa is conjugated to the peptide Gly-Arg-Gly-Asp-Thr-Pro (SEQ ID NO:1). This blended RNA ligand inhibits the biological activity of gpIIbIIIa with high specificity. Also described is a single-stranded DNA ligand to elastase coupled to N-methoxysuccinyl-Ala-Ala-Pro-Val-chloromethyl (SEQ ID NO:3) ketone. This elastase blended nucleic acid ligand inhibits the biological activity of elastase.Type: GrantFiled: October 23, 1997Date of Patent: July 4, 2000Assignee: NeXstar Pharmaceuticals, Inc.Inventors: Greg Biesecker, Sumedha D. Jayasena, Larry Gold, Drew Smith, Gary Kirschenheuter
-
Patent number: 5998142Abstract: This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.Type: GrantFiled: August 21, 1997Date of Patent: December 7, 1999Assignee: NeXstar Pharmaceuticals, Inc.Inventors: Larry Gold, Bruce Eaton, Drew Smith, Matthew Wecker, Kirk Jensen
-
Patent number: 5962219Abstract: This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.Type: GrantFiled: June 5, 1995Date of Patent: October 5, 1999Assignee: NeXstar Pharmaceuticals, Inc.Inventors: Larry Gold, Bruce Eaton, Drew Smith, Matthew Wecker, Kirk Jensen
-
Patent number: 5763595Abstract: This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.Type: GrantFiled: June 5, 1995Date of Patent: June 9, 1998Assignee: NeXstar Pharmaceuticals, Inc.Inventors: Larry Gold, Bruce Eaton, Drew Smith, Matthew Wecker, Kirk Jensen
-
Patent number: 5705337Abstract: This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.Type: GrantFiled: March 8, 1995Date of Patent: January 6, 1998Assignee: NeXstar Pharmaceuticals, Inc.Inventors: Larry Gold, Bruce Eaton, Drew Smith, Matthew Wecker, Kirk Jensen
-
Patent number: 5683867Abstract: A method is described for generating blended nucleic acid ligands containing non-nucleic acid functional units. Specifically, a SELEX identified RNA ligand to the integrin gpIIbIIIa is conjugated to the peptide Gly-Arg-Gly-Asp-Thr-Pro (SEQ ID NO:1). This blended RNA ligand inhibits the biological activity of gpIIbIIIa with high specificity. Also described is a single-stranded DNA ligand to elastase coupled to N-methoxysuccinyl-Ala-Ala-Pro-Val-chloromethyl (SEQ ID NO:2) ketone. This elastase blended nucleic acid ligand inhibits the biological activity of elastase.Type: GrantFiled: April 28, 1994Date of Patent: November 4, 1997Assignee: NeXstar Pharmaceuticals, Inc.Inventors: Greg Biesecker, Sumedha D. Jayasena, Larry Gold, Drew Smith, Gary P. Kirschenheuter